Free Trial

Myriad Genetics (MYGN) Earnings Date, Estimates & Call Transcripts

Myriad Genetics logo
$13.36 +0.19 (+1.44%)
(As of 12/20/2024 05:16 PM ET)
Get Myriad Genetics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Myriad Genetics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MYGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MYGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Myriad Genetics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242-$0.15-$0.13-$0.14 
Q2 20242-$0.07-$0.06-$0.07 
Q3 20242-$0.07-$0.06-$0.07 
Q4 20242-$0.04-$0.02-$0.03 
FY 20248-$0.33-$0.27-$0.30 
Q1 20251-$0.07-$0.07-$0.07 
Q2 20251-$0.04-$0.04-$0.04 
Q3 20251-$0.04-$0.04-$0.04 
Q4 20251-$0.02-$0.02-$0.02 
FY 20254($0.17)($0.17) ($0.17)

Myriad Genetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2024Q4 2024-$0.01$0.05+$0.06$0.21$206.44M$211.50M
5/7/2024Q1 2024-$0.10-$0.01+$0.09$0.01$193.51M$202.20M
2/27/2024Q4 2023$0.01$0.04+$0.03$0.22$194.80M$196.60M
11/6/2023Q3 2023-$0.08-$0.03+$0.05$0.41$179.23M$191.90M
8/3/2023Q2 2023-$0.08-$0.08-$1.00$187.16M$183.50M
5/3/2023Q1 2023-$0.19-$0.21 -$0.02$0.11$171.56M$181.20M
2/28/2023Q4 2022-$0.27-$0.20+$0.07$0.12$169.16M$177.80M

Myriad Genetics Earnings - Frequently Asked Questions

Myriad Genetics issued an update on its FY 2024 earnings guidance on Saturday, November, 30th. The company provided earnings per share (EPS) guidance of 0.120-0.140 for the period, compared to the consensus earnings per share estimate of 0.100. The company issued revenue guidance of $837.0 million-$843.0 million, compared to the consensus revenue estimate of $841.4 million.

Myriad Genetics (NASDAQ:MYGN) has a recorded annual revenue of $753.20 million.

Myriad Genetics (NASDAQ:MYGN) has a recorded net income of -$263.30 million. MYGN has generated -$1.30 earnings per share over the last four quarters.

Myriad Genetics's earnings are expected to grow from ($0.32) per share to ($0.21) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:MYGN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners